Healthcare Professional Survey to Assess the Effectiveness of Risk Evaluation and Mitigation Strategy for Dulaglutide (36 Month) (H9X-MC-B003)

01/08/2017
18/08/2017
EU PAS number:
EUPAS20159
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

H9X-MC-B003_Registered

English (242.43 KB - PDF) View document
Study results
Study report
Other information